What blood markers should I test before starting a sibutramine 20mg cutting cycle?

Before starting, test a full lipid panel (LDL-C, HDL-C, triglycerides), liver enzymes (ALT, AST, ALP), fasting glucose, full blood count, and record resting blood pressure and heart rate on two separate days. These baseline values give you the comparison points needed to detect meaningful shifts at your week-four retest. Skipping the baseline makes mid-cycle results uninterpretable.

How often should I get bloodwork done while using sibutramine during a diet?

Retest at week four, week eight, and at the end of your protocol — three panels total for a standard cycle. If you introduce any additional compound (anabolic or thyroid-related), add an extra panel two weeks after that addition. More frequent testing is warranted if any individual marker approaches its threshold value at the four-week check.

Which lab values mean I should stop sibutramine immediately?

Stop immediately if ALT or AST exceeds three times the upper limit of normal (3× ULN), if systolic blood pressure consistently reads above 145 mmHg, or if resting heart rate exceeds 100 bpm across two separate measurements taken on different days. These are hard biochemical and haemodynamic stopping criteria, not negotiable dose-reduction scenarios.

Why does the 20mg per-tablet concentration of GeTm Labs Sibutramine matter for dosing convenience?

At 20 mg per tablet — the highest concentration in this sibutramine product group — a single tablet covers the full therapeutic dose, eliminating the need to combine multiple lower-strength tablets. This reduces pill burden, simplifies daily tracking, and makes protocol adherence more straightforward across a 100-tablet supply. HPLC verification at production ensures each tablet delivers its declared 20 mg consistently.

Can I split GeTm Labs Sibutramine 20mg tablets to achieve a lower starting dose?

Tablets can be halved to achieve a 10 mg starting dose, which is a standard titration approach for users who want to assess individual tolerance before progressing to the full 20 mg. The tablet format supports clean splitting; however, the dose delivered from each half should be treated as approximate rather than analytically precise, as surface-area variation affects release. Confirm your individual response at 10 mg with a blood-pressure reading before advancing. (2) angle_used

Top Seller

GeTm Labs

Sibutramine 20mg 20mg/tab 100 Tabletten by GeTm Labs

Name: Sibutramine 20mg 20mg/tab 100 Tablets by GeTm Labs
Brand: GeTm Labs
SKU: WEIGHT-SIBU-GET-007
Price: 80.00 EUR
Availability: InStock
Rating: 5 (4 reviews)

5 (4 reviews)

GeTm Labs Sibutramine 20mg delivers the centrally acting serotonin–norepinephrine reuptake inhibitor sibutramine at a full 20 mg per tablet across 100 tablets — the highest per-tablet concentration available in this product group — making systematic blood-marker surveillance the defining clinical requirement of any protocol built around it. Because sibutramine simultaneously influences hepatic enzyme activity, lipid fractions, and haematological stress markers during a caloric deficit, baseline and follow-up laboratory panels are not optional safety theatre but the primary management tool. HPLC quantification and LAL endotoxin testing are applied at every GeTm Labs production run, with GMP-certified batch traceability embedded directly in the packaging documentation.

€80.00Free shipping on orders over €300

In stock

Ships within 48 h Lab-tested batch

Delivers a full 20 mg of sibutramine per tablet — the highest per-tablet concentration in the product group, reducing daily pill count to one.
HPLC-quantified active ingredient content at every production batch ensures dose reliability across all 100 tablets.
LAL endotoxin testing applied during manufacturing minimises contamination risk in each blister-packed tablet.
GMP-certified batch traceability allows users to cross-reference their laboratory panel data against a verified, consistent compound dose.
Serotonin and norepinephrine reuptake inhibition creates a dual-pathway metabolic effect relevant to monitoring both appetite and cardiovascular markers.
100-tablet pack volume provides sufficient supply to complete a protocol and two full rounds of interim bloodwork within the same purchase.
Tablet form supports clean halving for titration from 10 mg to 20 mg, giving users a structured tolerance-assessment phase.

Phase	Dosage	Note
Titration (Weeks 1–2)	10 mg / day (½ tablet)	Establish haemodynamic baseline; record resting BP and HR daily before escalating.
Maintenance (Weeks 3–8)	20 mg / day (1 tablet)	Retest full blood panel at end of Week 4; compare LDL-C and ALT to pre-cycle baseline.
Second monitoring window (Week 8)	20 mg / day or return to 10 mg if markers are trending	Dose decision guided by Week 4 lab results; hepatic and lipid values are primary decision inputs.
Exit (Week 9–10)	10 mg / day (½ tablet) for final 1–2 weeks	Final blood panel at protocol end; document all values for longitudinal comparison before any future cycle.

Key takeaways

Establish a full lipid and liver enzyme baseline before your first tablet.
Retest blood markers at weeks four, eight, and protocol end.
Stop immediately if ALT exceeds three times its upper limit of normal.
Track fasting triglycerides and HDL-C as primary cardiovascular load indicators.
Use the 20mg tablet format to simplify single-dose daily tracking and adherence.

What Lab Monitoring Actually Means for a Sibutramine Cutting Protocol

Sibutramine 20mg by GeTm Labs is a high-dose, tablet-form serotonin–norepinephrine reuptake inhibitor whose metabolic footprint during a structured fat-loss diet extends well beyond appetite regulation into measurable changes across multiple haematological and biochemical panels. Understanding which markers shift, how quickly they shift, and at what threshold they require protocol adjustment is the clinical core of responsible use. The 20 mg per-tablet concentration — the highest in this sibutramine product range — means that any laboratory deviation detected early costs the user far less than one caught late.

Baseline Panel: What to Measure Before Day One

A complete pre-protocol blood panel should include, at minimum: a full lipid profile (LDL-C, HDL-C, triglycerides), a comprehensive metabolic panel (ALT, AST, ALP, creatinine, fasting glucose), a full blood count (haemoglobin, haematocrit, platelet count), and a resting cardiovascular baseline (seated blood pressure and resting heart rate recorded on two separate days). Sibutramine raises LDL-C in a clinically meaningful proportion of users — documented in the SCOUT trial population — making lipid baseline essential rather than precautionary. Compared to lighter stimulant agents such as caffeine-based thermogenics, sibutramine's norepinephrine reuptake blockade produces measurable haematological sympathetic stress markers that caffeine compounds rarely shift at standard doses.

Mid-Cycle and Exit Monitoring: Frequency and Thresholds

Laboratory re-testing is clinically recommended at week four and week eight of a standard protocol, with an additional panel at discontinuation. ALT elevation above three times the upper limit of normal (>3× ULN) constitutes a hard biochemical stopping criterion irrespective of subjective tolerance. GeTm Labs formulates each 20 mg tablet under GMP-certified conditions with HPLC verification of active-ingredient content; this manufacturing consistency means that laboratory variation between panels reflects genuine physiological response rather than dose inconsistency from the compound itself. Fasting triglycerides and HDL-C are the two lipid sub-fractions that most reliably signal cardiovascular metabolic load during a deficit combined with sympathomimetic therapy.

Practical Marker Summary

Lipids: Recheck at week 4 — LDL rise >15 % from baseline warrants dietary intervention.
Hepatic enzymes: ALT/AST above 3× ULN = stop immediately.
Haemodynamic: Systolic BP consistently >145 mmHg or resting HR >100 bpm requires dose suspension.
Glucose: Fasting glucose trending above 100 mg/dL during a hypocaloric phase indicates insulin sensitivity monitoring.

Documenting each panel date alongside the corresponding protocol week number creates a longitudinal data trail that enables informed decisions at cycle close and informs any subsequent protocol design.

Usage

Complete your baseline blood panel — lipid profile, liver enzymes (ALT, AST, ALP), fasting glucose, full blood count, and two separate blood pressure readings — before taking your first tablet.
Begin at 10 mg (half a tablet) daily for the first two weeks, taken orally with water in the morning alongside a meal to reduce gastric discomfort.
Record your resting blood pressure and heart rate on at least three separate mornings during the titration phase and log results with the date.
Advance to the full 20 mg daily tablet only after confirming that resting BP remains below 140/90 mmHg and resting HR stays under 90 bpm across your titration-phase readings.
Schedule your four-week blood retest calendar appointment at the same time you begin the protocol — do not leave it as an unscheduled intention; LDL-C and ALT values at Week 4 are the primary go/no-go data for continuing at full dose.
At protocol close, complete your exit blood panel and store results alongside your Week 4 panel; this paired dataset forms the evidence base for any future protocol decision and should be reviewed with a qualified healthcare provider.

Warnings

Contraindications: Sibutramine 20mg is contraindicated in individuals with established coronary artery disease, congestive heart failure, arrhythmia, uncontrolled hypertension (>145/90 mmHg), prior stroke, severe hepatic impairment (Child-Pugh B/C), closed-angle glaucoma, or concurrent use of MAOIs. Do not use alongside other serotonergic or noradrenergic agents. Not suitable for persons under 18 or during pregnancy and lactation.

Side Effects: Commonly reported effects include dry mouth, insomnia, constipation, and elevated heart rate. Less common but clinically significant: palpitations, headache, paraesthesia, and transient ALT elevation. In populations with pre-existing cardiovascular risk, serious adverse events including non-fatal myocardial infarction and stroke have been documented (SCOUT trial data, NEJM 2010).

Monitoring: Blood pressure and resting heart rate should be self-monitored weekly and formally recorded at each clinic visit. Full lipid and hepatic enzyme panels at protocol start, Week 4, Week 8, and end of cycle are the minimum monitoring schedule. ALT above 3× ULN, systolic BP consistently above 145 mmHg, or resting HR persistently above 100 bpm each constitute independent stopping criteria requiring immediate discontinuation.

PCT: Sibutramine is not an anabolic agent and does not suppress the hypothalamic–pituitary–gonadal axis; formal post-cycle therapy targeting gonadotropin recovery is not applicable. However, a post-protocol blood panel is strongly recommended to confirm return of lipid fractions and hepatic enzymes to pre-cycle ranges before initiating any subsequent protocol.

Frequently asked questions

What blood markers should I test before starting a sibutramine 20mg cutting cycle?: Before starting, test a full lipid panel (LDL-C, HDL-C, triglycerides), liver enzymes (ALT, AST, ALP), fasting glucose, full blood count, and record resting blood pressure and heart rate on two separate days. These baseline values give you the comparison points needed to detect meaningful shifts at your week-four retest. Skipping the baseline makes mid-cycle results uninterpretable.
How often should I get bloodwork done while using sibutramine during a diet?: Retest at week four, week eight, and at the end of your protocol — three panels total for a standard cycle. If you introduce any additional compound (anabolic or thyroid-related), add an extra panel two weeks after that addition. More frequent testing is warranted if any individual marker approaches its threshold value at the four-week check.
Which lab values mean I should stop sibutramine immediately?: Stop immediately if ALT or AST exceeds three times the upper limit of normal (3× ULN), if systolic blood pressure consistently reads above 145 mmHg, or if resting heart rate exceeds 100 bpm across two separate measurements taken on different days. These are hard biochemical and haemodynamic stopping criteria, not negotiable dose-reduction scenarios.
Why does the 20mg per-tablet concentration of GeTm Labs Sibutramine matter for dosing convenience?: At 20 mg per tablet — the highest concentration in this sibutramine product group — a single tablet covers the full therapeutic dose, eliminating the need to combine multiple lower-strength tablets. This reduces pill burden, simplifies daily tracking, and makes protocol adherence more straightforward across a 100-tablet supply. HPLC verification at production ensures each tablet delivers its declared 20 mg consistently.
Can I split GeTm Labs Sibutramine 20mg tablets to achieve a lower starting dose?: Tablets can be halved to achieve a 10 mg starting dose, which is a standard titration approach for users who want to assess individual tolerance before progressing to the full 20 mg. The tablet format supports clean splitting; however, the dose delivered from each half should be treated as approximate rather than analytically precise, as surface-area variation affects release. Confirm your individual response at 10 mg with a blood-pressure reading before advancing. (2) angle_used

Manufacturer

GeTm Labs approaches pharmaceutical-grade oral tablet formulation through a development pipeline that centres on dose precision and analytical traceability. For this 20 mg sibutramine product, the formulation team selected a direct-compression tablet matrix that supports clean tablet splitting without crumbling — a deliberate engineering decision for users who require titration flexibility. Every production run undergoes HPLC quantification of active-ingredient content and LAL endotoxin assay on finished product, with GMP certification governing facility conditions, raw-material sourcing, and batch release criteria. GeTm Labs' approach to packaging documentation embeds batch-specific analytical data within the product traceability record, giving end users a direct link between the tablets they receive and the quality data generated during manufacture.

Product details

Brand	GeTm Labs
Active ingredient	sibutramine
Also known as	Sibutramin, Meridia, Reductil, Sibutramine 20mg, GeTm Labs Sibutramin
Strength	20 mg
Form	Tabletten
Pack size	100 pieces
Item number	WEIGHT-SIBU-GET-007

Reviews

5/5

4 reviews

Rating: 5 out of 5 starssavageVerified purchaseAug 2, 2026
Appetite completely gone
running 10mg daily for 8 weeks as part of my cut. Went from 98kg to 89kg. the appetite suppression is insane, genuinely forget to eat some days. Energy levels stayed up even in a 600 cal deficit. Packaging was spot on, no issues with delivery whatsoever...
Rating: 5 out of 5 starsLeon87Verified purchaseJul 28, 2026
Legit product, fast delivery
Used GeTm sibu at 15mg daily for 6 weeks. Lost 7kg, kept all my strength in the gym which is impressive on that kind of deficit. Dry mouth was the only side and that's expected. Came well packaged, arrived in 5 days. Reordered already.
Rating: 5 out of 5 starsLeon87Verified purchaseJun 27, 2026
Best cut I've had in years
10mg Swiss Pharm sibu alongside 300mg test e per week for 10 weeks. Dropped from 107kg to 94kg. Bloodwork at week 8 showed everything reasonable, kept training intensity high throughout. Sleep was slightly lighter but manageable. Would absolutely run again next cut cycle.
Rating: 5 out of 5 starsbull58Verified purchaseJun 23, 2026
Consistent quality every time
third order of GeTm sibutramine now. Always the same quality. I dose 10mg for the first two weeks then bump to 20mg for the remaining 6. This time dropped from 104kg to 93kg over 8 weeks. Appetite suppression is strong and consistent through the whole run. No complaints!

Write a review

Reviews are written by users of this shop and are checked editorially before publication. Unless labelled “Verified purchase”, we do not verify that the review is based on an actual purchase.

Similar products

Lab Tested

Meridia 15mg/tab 90 Tabletten by Abbott

Meridia by Abbott delivers Sibutramine Hydrochloride at a precisely dosed 15 mg per tablet — a centrally acting appetite suppressant that prolongs postprandial satiety and reduces caloric intake by modulating norepinephrine, serotonin, and dopamine reuptake simultaneously. Cutting phases become measurably more manageable when hunger signals are blunted at the neurochemical level, allowing athletes to sustain a deficit without the relentless cravings that derail progress. Quality is verified through independent HPLC purity analysis and LAL endotoxin screening; every production run adheres to GMP-certified manufacturing standards.

€80.00

HPLC Verified

Meridia 15mg/tab 30 Tabletten by Abbott

Sibutramine 15 mg — a centrally acting monoamine reuptake inhibitor available as oral tablets — carries a clinically documented cardiovascular burden characterised by elevated resting heart rate, increased systolic and diastolic blood pressure, and heightened cardiac output that users must account for before and during any cycle. Blood pressure spikes and tachycardia represent the most commonly reported serious adverse events observed in clinical populations using this compound at therapeutic and supra-therapeutic doses. Each tablet's purity and exact dose are confirmed through HPLC analysis conducted at Abbott's quality-control laboratory, ensuring the cardiovascular risk calculation begins with a precisely labelled product.

€25.00

Reductil 15mg 15mg/tab 14 Tablets by Abbott

Pharma Grade

Reductil 15mg 15mg/tab 14 Tabletten by Abbott

Reductil 15mg by Abbott delivers sibutramine hydrochloride monohydrate at 15 mg per tablet — a centrally acting monoamine reuptake inhibitor whose sympathomimetic activity creates measurable cumulative cardiac demands when co-administered alongside anabolic-androgenic steroids or other stimulatory compounds. Each 14-tablet blister pack supports precision dosing in contexts where stack-related cardiovascular load — spanning blood pressure elevations, lipid-profile shifts, and resting heart rate increases — must be systematically tracked and managed. Quality assurance is embedded at the batch level: HPLC quantification and LAL endotoxin testing are applied under cGMP conditions before any pack reaches the end user.

€15.00

Sibutramine 20mg 20mg/tab 30 Tablets by EU

Purity Tested

Sibutramine 20mg 20mg/tab 30 Tabletten by EU

EU Sibutramine 20mg delivers 20 milligrams of sibutramine hydrochloride per tablet — a centrally acting serotonin–norepinephrine reuptake inhibitor formulated specifically so that practitioners can align intake timing with the compound's pharmacokinetic window for maximum thermogenic and appetite-modulating effect. Each 30-tablet pack is engineered around the question of when, not merely whether, to dose: morning administration capitalises on the compound's ~14–16 hour active metabolite half-life, while pre-cardio timing leverages catecholamine sensitisation during aerobic work. HPLC quantification and LAL endotoxin screening are applied to every production lot; GMP-certified EU manufacturing ensures the declared 20 mg per tablet is analytically confirmed before release.

€25.00

Stack it with

Pairs well with these products.

High Concentration

Quant-Equipoise 300mg/ml 10ml Vial by Beligas Pharmaceuticals

Quant-Equipoise by Beligas Pharmaceuticals is a high-concentration injectable anabolic agent delivering 300 mg of Boldenone Undecylenate per millilitre in a 10 ml multi-dose vial, purpose-built for integration into contemporary cycle structures where weekly injection frequency and volume efficiency are primary design criteria. The compound's extended ester profile supports low-frequency administration windows that align with modern 7-day dosing blocks used in both bulking and body-recomposition protocols. Quality assurance is enforced at two independent checkpoints: HPLC-verified potency assay and LAL bacterial endotoxin testing — both completed before batch release under Beligas's GMP-certified production framework.

€47.00

Bolden-250 250mg/ml 10x1ml Ampoules by BM Pharmaceuticals

Long-Acting Formula

Bolden-250 250mg/ml 10x1ml Ampullen by BM Pharmaceuticals

Bolden-250 is a veterinary-derived anabolic compound reformulated for human performance use, delivering Boldenone Undecylenate at 250 mg/ml via single-dose ampoule — distinguished by its exceptionally prolonged plasma half-life of approximately 14 days, which governs the entire pharmacokinetic profile and dictates injection scheduling. The undecylenate ester attached to the boldenone base controls the rate of hydrolysis in muscle tissue, producing a slow, steady release curve that maintains stable serum concentrations over extended periods. Quality verification is built into every step of production: HPLC-confirmed potency, LAL endotoxin screening, and GMP-compliant fill-finish at BM Pharmaceuticals' certified facility.

€48.00

Brand Quality

EquiTrex 350mg/ml 10ml Vial by Concentrex Labs

EquiTrex is a high-concentration boldenone undecylenate injectable — 350 mg per millilitre in a 10 ml vial — engineered to serve distinct roles across both the blast and cruise phases of a structured performance cycle. Its extended ester release supports stable androgen exposure during lower-dose cruise periods while delivering meaningful anabolic output when dose is escalated during a blast. Quality assurance at Concentrex Labs is built on HPLC potency verification and LAL endotoxin screening; every released batch carries documented evidence of sterility and concentration accuracy.

€52.00

Pro Choice

EQ 300 300mg/ml 10ml Vial by Dragon-Pharma

Dragon-Pharma EQ 300 delivers Boldenone Undecylenate at 300 mg/ml in a 10 ml multi-dose vial, formulated specifically for older athletes and TRT-adjacent users who require a mild yet effective anabolic agent to complement age-related hormonal management strategies. Its gradual plasma release profile makes it particularly suited to the steadier hormonal environment that men over 40 typically need to maintain lean mass, bone density support, and nitrogen retention without the volatility of shorter-ester androgens. Quality is assured at the batch level: every vial passes HPLC content verification and LAL endotoxin screening before release under full GMP compliance.

€44.00